Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Director departure
|
ABEONA THERAPEUTICS INC. (ABEO)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/10/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
09/29/2023 |
4
| Seshadri Vishwas (CEO) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 13,290 shares
@ $3.93, valued at
$52.2k
|
|
09/29/2023 |
4
| Vazzano Joseph Walter (CFO) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 6,230 shares
@ $3.93, valued at
$24.5k
|
|
09/29/2023 |
4
| O'Malley Brendan M. (SVP, General Counsel) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 6,557 shares
@ $3.93, valued at
$25.8k
|
|
09/29/2023 |
4
| Alvino Mark (Director) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Sold 6,316 shares
@ $3.9145, valued at
$24.7k
|
|
09/29/2023 |
4
| Alland Leila (Director) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Sold 7,246 shares
@ $3.9014, valued at
$28.3k
|
|
09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/08/2023 |
8-K
| Quarterly results |
08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/07/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
07/06/2023 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 15.3% stake in Abeona Therapeutics Inc. |
07/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data
Docs:
|
"PRE-FUNDED COMMON STOCK PURCHASE WARRANT Abeona Therapeutics Inc. Warrant Shares : ______________ Issue Date: July ___ , 2023 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT certifies that, for value received, [●] or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof until this Warrant is exercised in full but not thereafter, to subscribe for and purchase from Abeona Therapeutics Inc., a Delaware corporation , up to _____ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and not otherwise defined herein shall have the meani...",
"Tel: 212 728 8000 Fax: 212 728 8111",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of July 3, 2023, between Abeona Therapeutics Inc., a Delaware corporation , and the purchasers identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act of 1933, as amended and the rules and regulations of the Securities and Exchange Commission thereunder, the Company desires to issue and sell to the several Purchasers, and the several Purchasers desire to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration t...",
"Abeona Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules" |
|
07/03/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
06/16/2023 |
4
| Alvino Mark (Director) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Granted 58,689 shares
@ $4.62, valued at
$271.1k
|
|
06/16/2023 |
4
| Amoroso Michael (Director) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Granted 58,689 shares
@ $4.62, valued at
$271.1k
|
|
06/16/2023 |
4
| Charles Faith L. (Director) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Granted 58,689 shares
@ $4.62, valued at
$271.1k
|
|
06/16/2023 |
4
| Silverstein Christine Berni (Director) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Granted 58,689 shares
@ $4.62, valued at
$271.1k
|
|
06/16/2023 |
4
| Wuchterl Donald A. (Director) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Granted 58,689 shares
@ $4.62, valued at
$271.1k
|
|
06/16/2023 |
4
| Alland Leila (Director) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Granted 58,689 shares
@ $4.62, valued at
$271.1k
|
|
06/07/2023 |
4
| Seshadri Vishwas (CEO) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Granted 336,826 shares
@ $0 |
|
06/07/2023 |
4
| Vazzano Joseph Walter (CFO) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Granted 141,908 shares
@ $0 |
|
06/07/2023 |
4
| O'Malley Brendan M. (SVP, General Counsel) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Granted 90,902 shares
@ $0 |
|
06/07/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
06/06/2023 |
4
| Seshadri Vishwas (CEO) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 827 shares
@ $3.06, valued at
$2.5k
|
|
05/19/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
05/17/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/11/2023 |
8-K
| Quarterly results |
05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/19/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
04/13/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
04/05/2023 |
4
| O'Malley Brendan M. (SVP, General Counsel) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Paid exercise price by delivering 104 shares
@ $2.82, valued at
$293.3 |
|
|
|
|